Skip to main content

Advertisement

Table 1 Comparisons of patients’ clinical characteristics between the aBVA and VAB cohorts

From: Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patients

Variable Total (n = 301) aBVA cohort (n = 109) VAB cohort (n = 192) P
Age [years, median (range)] 62 (30–83) 62 (35–81) 62 (30–83) 0.966
Female [cases (%)] 186 (61.8) 65 (59.6) 121 (63.0) 0.561
Smoker [cases (%)] 101 (33.6) 39 (35.8) 62 (32.3) 0.538
Neoadjuvant therapy [cases (%)] 13 (4.3) 4 (3.7) 9 (4.7) 0.775*
Histological subtype [cases (%)]
 Adenocarcinoma 248 (82.4) 98 (89.9) 150 (78.1) 0.033
 Squamous cell carcinoma 37 (12.3) 7 (6.4) 30 (15.6)  
 Others 16 (5.3) 4 (3.7) 12 (6.3)  
TNM stage [cases (%)] 0.539*
 I 209 (69.4) 80 (73.4) 129 (67.2)  
 II 42 (14.0) 12 (11.0) 30 (15.6)  
 III 44 (14.6) 16 (14.7) 28 (14.6)  
 IV 6 (2.0) 1 (0.9) 5 (2.6)  
  1. aBVA right upper lobectomy (RUL) with the dissecting order of the posterior ascending arterial branch [a], followed by the right upper bronchus [B] and pulmonary vessels [VA]; VAB RUL with the dissecting order of the right upper pulmonary veins and arteries [VA], followed by the right upper bronchus [B]
  2. * Fisher’s exact test